Best adjuvant (assist) for chemotherapy | 1+1>487% |

Effectively improve chemotherapy effect, treatment, immunity |

Reduce side effects and recurrence |

Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work |

Abstract / Summary / Overview of Apoptosis

Why do cells undergo apoptosis?

The relationship between cancer cells and apoptosis

Where are the weaknesses and symptoms of cancer cells?

Are cancer cells aggressive?

Extraordinary Solamargine (Role, Principle, Action, Mechanism, Function, Work)

Solamargine's major function mechanism:

Solamargine vs cancer

Best Chemotherapy Adjuvant (1+1>478%) Effectively improve chemotherapy effect and cure

Best adjuvant (assist) for chemotherapy | 1+1>487%

Effectively improve chemotherapy effect, treatment, immunity

Reduce side effects and recurrence

Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work

Abstract / Summary / Overview of Apoptosis

Overview of apoptosis

•Programmed cell death

•Apoptosis is a form of programmed cell death, or “cellular suicide.”

•Apoptosis is different from necrosis, in which cells die due to injury.

•Apoptosis removes cells during development, eliminates potentially cancerous and virus-infected cells, and maintains balance in the body.

Why do cells undergo apoptosis?

Basically, apoptosis is a general and convenient way to remove cells that should no longer be part of the organism.
Some cells are abnormal and could hurt the rest of the organism if they survive, such as cells with viral infections or DNA damage.
Apoptosis is part of development
In many organisms, programmed cell death is a normal part of development.

The relationship between cancer cells and apoptosis

Apoptosis can eliminate infected or cancerous cells.

When a cell’s DNA is damaged, it will typically detect the damage and try to repair it.

If the damage is beyond repair, the cell will normally send itself into apoptosis, ensuring that it will not pass on its damaged DNA.

When cells have DNA damage but fail to undergo apoptosis, they may be on the road to cancer.

However, “successful” cancer cells successfully evade the process of apoptosis.

This allows them to divide out of control and accumulate mutations (changes in their DNA).

Apoptosis is key to immune function

Apoptosis also plays an essential role in the development and maintenance of a healthy immune system.

Where are the weaknesses and symptoms of cancer cells?

The symptoms of cancer cells are in the nucleus.

The nucleus controls the outer cytoplasm, cell composition, cell viability, etc.

DNA mutations also mutate in the nucleus.

Therefore, to treat cancer cells, we must first enter the nucleus.

Let the “regulatory cell gene” mechanism enter the nucleus to regulate

Are cancer cells aggressive?

After the action of Solamargine, the aggressiveness of cancer cells is alleviated.

So after using Solamargine, many patients feel that I am half better.

Although the tumor does not disappear quickly, patients feel that the degree of aggressiveness is reduced.

Extraordinary Solamargine (Role, Principle, Action, Mechanism, Function, Work)

Solamargine's major function mechanism:

When Solamargine enter,

Solamargine activates receptors that are turned off by cancer cells, allowing cancer cells to modulate again.

Solamargine modulates the anti-modulates genes of cancer cells, making cancer cells less resistant.

Reduced drug resistance

When cancer cells are less resistant to drugs, chemotherapy becomes more effective.

Solamargine modulates the mutated genes in cancer cells and then initiates cancer cell apoptosis to achieve anti-cancer effects.

Solamargine combined with which chemotherapy drugs are more effective in treating cancer cells?

Solamargine vs cancer

cell apoptosis.jpg

Solamargine vs cancer

The picture shows the death of cancer cells.

The black and black parts are cancer cell nuclei.

Even if the nucleus ruptures, the cancer cells will die.

The figure shows that cancer cells can cause death.

cancer cell apoptosis_01_800.jpg

The figure shows that cancer cells can cause death.

The figure shows that the death of lung cancer cells is relatively slow, and it will not be obvious until eight hours later.

The figure shows that the death of liver cancer cells is very obvious, even more obvious in eight hours.

The graph shows that breast cancer cells die faster. It was obvious from the beginning that breast cancer is easy to treat, and patients with breast cancer need not worry.

Best Chemotherapy Adjuvant (1+1>487%) Effectively improve chemotherapy effect and treatment

ANTI-CANCER

Patent protection in 32 nations.

A comparison study showing Solamargine vs. other therapeutic drugs with respect to lung cancer cells.

A comparison study showing Solamargine vs. other chemotherapeutic drugs with respect to breast cancer cells

solamargine combined treatment therapy_01_800.jpg

SR-T100 combination therapy with effective result against breast cancer cells.

solamargine combined treatment therapy_03R12_800.jpg

Combination Therapy | Research results for lung cancer cells.

A. Chemotherapy (100μM), 16% of cancer cell apoptosis.

B. Alone SM (4.8μM), 28% of cancer cell apoptosis.

C. SM (4.80μM) + Chemotherapy (40μM), 66% of cancer cells apoptosis.

D. SM (4.80μM) + Chemotherapy (100μM), 78% of cancer cell apoptosis.

SM has a clearing effect better than Chemotherapy.

The combined treatment of Solamargine and Chemotherapy significantly increased the apoptosis of lung cancer cells.

SM (4.8μM) + Chemotherapy (40μM), increased from 16% to 66% (up to 4.125 times).

SM (4.8μM) + Chemotherapy (100μM), increased from 16% to 78% (up to 4.875 times)

Reorganized from: BBRC. Action of Solamargine on TNFs and drug-resistant human lung cancer cells 2004

The best solution for cancer cells

Solamargine Q&A (English)

Cancer Medical Care | Side Effects of Chemotherapy | Improve Anemia | Improve Low Red Blood Cells | Improve Low Hemoglobin (Decrease/Decrease/Decrease/Insufficiency)

Cancer Medical Care | Chemotherapy by-products | Leukopenia | Neutropenia

Cancer Medical Care | Chemotherapy Side Effects| Improve Bleeding| Improve Platelet Decrease| Improve Platelet Deficiency| Improve Platelet Low| Improve Thrombocytopenia

Cancer Medical Care | Six indicators of physical health self-assessment: sleep, appetite, excretion, physical strength, mental strength, and psychology (emotion, mind)

Chemotherapy | Increase cure rate
Reduce cancer recurrence
Apoptotic (Correct/ Guide) bad behavior
Cure all diseases | Panacea | Package health
How to Longevity?
Want to Change?
Life Above All | Release life is best for oneself (me / yourself)
Eliminate misfortune!
Good affinities with others.
Beauty in Nature

survival rate | cancer | Contents
survival rate | cancer | Etymology and definitions
survival rate | cancer | Signs and symptoms
survival rate | cancer | Local symptoms
survival rate | cancer | Systemic symptoms
survival rate | cancer | Metastasis
survival rate | cancer | Causes
survival rate | cancer | Chemicals
survival rate | cancer | Diet and exercise
survival rate | cancer | Infection
survival rate | cancer | Radiation
survival rate | cancer | Heredity
survival rate | cancer | Physical agents
survival rate | cancer | Hormones
survival rate | cancer | Autoimmune diseases
survival rate | cancer | Pathophysiology
survival rate | cancer | Genetics
survival rate | cancer | Epigenetics
survival rate | cancer | Metastasis
survival rate | cancer | Metabolism
survival rate | cancer | Diagnosis
survival rate | cancer | Classification
survival rate | cancer | Prevention
survival rate | cancer | Dietary
survival rate | cancer | Medication
survival rate | cancer | Vaccination
survival rate | cancer | Screening
survival rate | cancer | Recommendations
survival rate | cancer | Genetic testing
survival rate | cancer | Management
survival rate | cancer | Cancer
survival rate | cancer | Radiation
survival rate | cancer | Surgery
survival rate | cancer | Palliative care
survival rate | cancer | Immunotherapy
survival rate | cancer | Laser therapy
survival rate | cancer | Alternative medicine
survival rate | cancer | Prognosis
survival rate | cancer | Epidemiology
survival rate | cancer | History
survival rate | cancer | Society and culture
survival rate | cancer | Economic effect
survival rate | cancer | Workplace
survival rate | cancer | Research
survival rate | cancer | Pregnancy
survival rate | cancer | Other animals
survival rate | cancer | Notes
survival rate | cancer | Further reading
survival rate | cancer | External links
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Contents
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Etymology and definitions
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Signs and symptoms
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Local symptoms
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Systemic symptoms
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Metastasis
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Causes
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Chemicals
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Diet and exercise
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Infection
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Radiation
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Heredity
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Physical agents
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Hormones
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Autoimmune diseases
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Pathophysiology
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Genetics
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Epigenetics
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Metastasis
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Metabolism
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Diagnosis
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Classification
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Prevention
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Dietary
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Medication
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Vaccination
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Screening
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Recommendations
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Genetic testing
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Management
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Chemotherapy
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Radiation
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Surgery
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Palliative care
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Immunotherapy
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Laser therapy
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Alternative medicine
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Prognosis
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Epidemiology
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | History
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Society and culture
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Economic effect
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Workplace
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Research
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Pregnancy
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Other animals
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Notes
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | Further reading
Островковноклеточная карцинома | Эндокринная карцинома поджелудочной | выживаемости | External links